Basics iTeos Therapeutics, Inc. IPO Date: June 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $448.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 2.72% Avg Daily Range (30 D): $0.03 | 0.30% Avg Daily Range (90 D): $0.05 | 0.48% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): M Avg Daily Volume (90 D): .7M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 448 Avg Trade Size (Sh.) (90 D): 152 Institutional Trades Total Inst.Trades: 1,150 Avg Inst. Trade: $2.01M Avg Inst. Trade (30 D): $6.53M Avg Inst. Trade (90 D): $1.98M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $52.45M Avg Closing Trade (90 D): $3.21M Avg Closing Volume: 103.93K     News Jul 26, 2025 @ 5:36 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 22, 2025 @ 12:39 AM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 21, 2025 @ 7:59 PM $HAREHOLDER ALERT: The M&A Class Action Firm Annou... Source: Juan Monteverde Jul 21, 2025 @ 11:29 AM iTeos Therapeutics Enters into Agreement to Be Acq... Source: Globe Newswire Apr 29, 2025 @ 9:47 PM iTeos publie les résultats financiers de son pr... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.81 $-.8 $-1.03 Diluted EPS $-1.81 $-.8 $-1.03 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -78.73M $ -34.61M $ -43.71M Operating Income / Loss $ -83.79M $ -40.02M $ -49.33M Cost of Revenue $ $ $ Net Cash Flow $ 49M $ 13.96M $ 19.4M PE Ratio